HS 2017 code 3002.19: Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes : — Other #
This subheading was considered by the HS Committee (HSC) as empty and was deleted in HS 2022.
In HS 2012, there was no subdivision for subheading 3002.10, which had the same title as the current 3002.1 (see below).
– Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes :
In HS 2017, the HSC decided to subdivide subheading 3002.10, creating new subheadings, 3002.12/13/14/15, for specific product groups and 19 for ‘other’.
Antisera, other blood fractions goes into 3002.12
immunological products fall under 3002.13/14/15 depending on whether they are mixed or unmixed, and depending on being in measured doses or in forms or packings for retail sale.
3002.13 – unmixed, not put up in measured doses or in forms or packings for retail sale.
3002.14 – mixed, not put up in measured doses or in forms or packings for retail sale.
3002.15 – put up in measured doses or forms or packings for retail sale.
That is, 3002.15 covers both unmixed and mixed products, which leaves nothing for 3002.19, there are no ‘other’ products. The HSC realised this shortly after the introduction of the new subheadings in 2017, but had to wait until 2022 to delete 3002.19. The fact that the code is empty means that there is no correlation with another code, it was simply a mistake made in HS 2017, subheading 19 should never have been created. However, some people used 3002.19 based on HS 2017. This was clearly a misclassification.
It should also be noted that if there were goods that were misclassified into subheading 3002.19, then there is no way to know which subheading it should have been in without knowing what each such shipment contained. Hence, its existence in HS 2017 would have distorted true trade statistics up to the degree it was used if any use.
The WCO correlation tables for HS 2022-2017 and HS 2017-2022 (https://www.wcoomd.org/en/topics/nomenclature/instrument-and-tools/hs-nomenclature-2022-edition/correlation-tables-hs-2017-2022.aspx) covered this as follows:
HS 2022-2017
HS 2017-2022
HS 2022 code 3822.19: Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits : — Other #
In HS 2017, heading 38.22 had no subdivision. At this time, the HSC discussed a number of diagnostic reagents for e.g. malaria and viral diseases transmitted by Aedes mosquitos. It was proposed to gather all kinds of diagnostic and laboratory reagents under one heading, seeing as they could at that point be classified under three different headings 38.22, 30.06 and 30.02. It can be noted that the title of 38.22 refers only to reagents on a backing and prepared reagents, that is, the substance or product that creates the reaction needed for the reagent, if presented unprepared or not on a backing, will be classified according to its composition. This is where the connection to 30.02 comes in.
The part of the reagent that creates the reaction may very well be a product of heading 30.02, e.g. an immunoglobulin. It could therefore be classified in 30.02, and as mixed products, whether or not in measured doses …, can be classified there, we would have two possible classifications for reagents containing immunological products. However, Note 1 (ij) to Chapter 30, excluding diagnostic reagents of heading 38.22 from Chapter 30, was created to solve this problem. This is why there is a correlation between subheadings 3002.13/14/15 and 38.22, but nothing for 3002.19.
Several products of heading 30.02, including the specifically mentioned diagnostic reagents for malaria, and reagents based on immunological products, were moved to heading 38.22. This was made to simplify the classification of diagnostic and laboratory reagents. It is no longer necessary to look into what part of the reagent creates the reaction to classify the product. Classification is now based on what diagnosis/analysis the reagent is intended.
There is no relationship between subheadings 3822.19 and 3002.19.
